EDAR Antikörper (AA 290-339)
Kurzübersicht für EDAR Antikörper (AA 290-339) (ABIN6738597)
Target
Alle EDAR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 290-339
-
Spezifität
- Human EDAR
-
Homologie
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Bovine, Horse (100%) Guinea pig, Chicken (92%) Rabbit, Pig (91%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa290-339 of human EDAR (Q9UNE0, NP_071731). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Galago, Marmoset, Mouse, Rat, Panda, Dog, Bovine, Bat, Horse (100%), Elephant, Opossum, Guinea pig, Turkey, Zebra finch, Chicken, Lizard (92%), Rabbit, Pig (91%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:12500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled Water.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- EDAR (Ectodysplasin A Receptor (EDAR))
-
Andere Bezeichnung
- ED3 / EDAR
-
Hintergrund
-
Name/Gene ID: EDAR
Synonyms: EDAR, Ectodysplasin-A receptor, ED1R, EDA-A1 receptor, EDA1R, DL, Downless, mouse, homolog of, ED3, EDA3, ECTD10A, ECTD10B, Ectodysplasin A receptor, ED5, Downless homolog, Ectodermal dysplasia receptor, EDA-A1R, HRM1 -
Gen-ID
- 10913
-
NCBI Accession
- NP_071731
-
UniProt
- Q9UNE0
-
Pathways
- Tube Formation, Ubiquitin Proteasome Pathway
Target
-